2008
DOI: 10.1016/j.vascn.2008.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 34 publications
0
8
0
Order By: Relevance
“…Non-radioactive endpoints, such as lymph node weight, cell proliferation and ear swelling, have been described by several authors (Ehling et al 2005a, b;Suda et al 2002;for review: Anderson et al 2011). Two versions of the LLNA with non-radioactive endpoints, the LLNA: DA and the BrdU-ELISA-version, are currently validated and available as draft OECD guidelines (Omori et al 2008;Kojima et al 2011). Ulrich et al (2001 described a two-tiered murine local lymph node assay and proposed that it is useful to discriminate between contact allergenic potential and skin irritation potential.…”
Section: Discussionmentioning
confidence: 99%
“…Non-radioactive endpoints, such as lymph node weight, cell proliferation and ear swelling, have been described by several authors (Ehling et al 2005a, b;Suda et al 2002;for review: Anderson et al 2011). Two versions of the LLNA with non-radioactive endpoints, the LLNA: DA and the BrdU-ELISA-version, are currently validated and available as draft OECD guidelines (Omori et al 2008;Kojima et al 2011). Ulrich et al (2001 described a two-tiered murine local lymph node assay and proposed that it is useful to discriminate between contact allergenic potential and skin irritation potential.…”
Section: Discussionmentioning
confidence: 99%
“…After thorough evaluation and reviews, these tests were adopted by The Organisation for Economic Co-operation and Development (OECD) as stand-alone skin sensitizing tests: Test Guideline (TG) 429, TG442A, and TG442B (Kimber et al, 1986;Basketter et al, 1996;Gerberich et al, 2000;Dean et al, 2001;Haneke et al, 2001;Takeyoshi et al, 2001;Sailstad et al, 2001;OECD TG No. 429, 2002, 2010bYamashita et al, 2005;Idehara et al, 2008;Omori et al, 2008;ICCVAM, 2010;OECD TG No. 442A, 2010a;OECD TG No.…”
Section: Introductionmentioning
confidence: 99%
“…The LLNA:DA employs ATP measurement as an index of lymph node cell proliferation, with principles of evaluation similar to those of the LLNA. The reliability and relevance of the LLNA:DA were examined by a committee and have been validated by 17 laboratories belonging to that committee (Omori et al, 2008). These LLNA methods have several advantages over the GPMT/BA, including generation of quantitative data, a reduction in test time, a reduction in the required number of animals, and an improvement in animal welfare (Haneke et al, 2001;Basketter et al, 1996).…”
Section: Introductionmentioning
confidence: 99%